APTEΞUS
  • Home
  • About
    • Apteeus
    • the team
    • our partners
    • our news
  • STOP Orphan
  • Technology
  • Programs
  • Contact-us
  • linkedin
  • facebook
  • youtube
  • Français
05/07/2021

The beginning of clofoctol story in covid19

Partagez cet article

You will read why we decided to run clinical trials with clofoctol in covid19…

Large scale screening discovers clofoctol as an inhibitor of SARS-CoV-2 replication that reduces COVID-19-like pathology | bioRxiv

Previous articleHERE WE ARE, THE CLOFOCTOL TRIAL IN COVID19 WILL BEGIN!Next article 15th edition of the Rare Disease Day

Recent Posts

The ? The peroxisome !09/08/2023
8.8 million euros for accelerated drug repurposing for rare neurological disorders18/04/2023
In 2023, we will again associate empathy and humanity with our discoveries and our achievements. Apteeus wish you the best!17/01/2023

Categories

  • News

Archives

  • August 2023
  • April 2023
  • January 2023
  • March 2022
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • March 2020
  • November 2019
  • October 2019
  • February 2019
  • December 2018
  • April 2018
  • January 2018
  • November 2017
  • October 2017
  • June 2017
  • January 2017
  • October 2016
  • August 2016
  • April 2015
  • December 2014
  • October 2014

CONTACT

APTEEUS SAS
Campus Institut Pasteur de Lille
1 rue du Professeur Calmette
59000 Lille - France

NEWS

The ? The peroxisome !09/08/2023
8.8 million euros for accelerated drug repurposing for rare neurological disorders18/04/2023

LINKS

General conditions

Join APTEΞUS

Orphanet

APTEΞUS ©2014-2023 - Tous droits réservés - Conception: